Human 3 with Brom and Sam15 Mai 2025

Top 10 Human 3 startups - brain implants, concierge longevity medicine, designer psychedelics and more

Brom Rector and Sam Tabone from XEIA get specific on what Human 3 actually looks like in practice by analyzing 10 startups through the Human 3 lens.

We analyze the companies on the 5 pillars of Human 3

Distribution shifting potential - can this company elevate the already healthy in addition to healing the sick?
HERO - is the company inspired by Historical Examples of Real-world Outcomes
Step Change potential - if this thing works, will it be an order of magnitude better than the standard of care?
Endogenous Accelerant - does the company have a built in flywheel?
X-disciplinarity - does the innovation happen at the intersection of multiple disciplines?

Timestamps and companies mentioned:

0:00 - what defines a Human 3 startup?

16:00 - Mindstate Design Labs: AI designed psychedelic therapies

25:00 - Kadence Bio: treatment for premature ejaculation

34:20 - NeuroBionics: minimally invasive deep brain stimulation for Parkinson's

42:00 - Motif Neurotech: minimally invasive TMS for depression

51:45 - Xylo Bio: non-hallucinogenic psychedelics

1:01:45 - Pangea Bio: AI to identify natures hidden cures

1:11:00 - Kerna Labs: AI model to unlock the therapeutic potential of mRNA

1:20:00 - Superpower: concierge longevity medicine on your iPhone

1:30:00 - Coherence: closed loop neuromodulation to treat brain cancer (Glioblastoma)

1:40:27 - Beond: treating Opiate addiction with Ibogaine

1:52:00 - closing thoughts

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(32)

$HIMS Q2 Results - our take as healthcare venture capitalists

Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health, wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. W...

5 Aug 20251h 24min

Investing in Psychedelic BioTech [August 2025 webinar replay]

Watch the video recording on YouTube: https://youtu.be/BM6x59oMnKg?si=qF0xDvgUMvU60ctP2025 has been the start of a bull period for psychedelic medicine.Psychedelic Biotechs like GH Research, Compass ...

30 Jul 202558min

Compass and ATAI latest news + are Psychedelics BACK in 2025?!

The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make...

29 Jul 202516min

Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field

Ryan Field is the CEO of Kernel, a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge, non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI w...

22 Jul 20251h 33min

How to start a VC fund

I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and SyndicationsThis is a great listen for anyone interested in start...

15 Jul 20251h 20min

Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]

Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: psybio.org

12 Jul 20251h 9min

Designing Novel Brain Drugs with Xylo Bio

Xylo is a biotech startup that is using computational methods to design novel brain drugs to treat mental health disorders and neurodegeneration. Many of their drug candidates are inspired by naturall...

8 Jul 20251h

The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup

Arye Lipman is the cofounder of Biosphere, a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufactu...

30 Jun 20251h 20min